[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618337":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":11,"studyPopulation":11,"armGroups":24,"interventions":37,"overallOfficials":11,"centralContacts":46,"locations":11,"responsibleParty":52,"collaborators":11,"id":54,"slug":11,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":58,"conditions":69,"keywords":71,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":11},{"fullName":5,"class":6},"Joincare Pharmaceutical Group Industry Co., Ltd","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Annualised rate of moderate or severe COPD exacerbations",null,"during 52 weeks of treatment",{"allocation":14,"interventionModel":15,"interventionModelDescription":11,"primaryPurpose":16,"observationalModel":11,"timePerspective":11,"maskingInfo":17},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":18,"maskingDescription":11,"whoMasked":19},"QUADRUPLE",[20,21,22,23],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[25,31],{"label":26,"type":27,"description":28,"interventionNames":29},"Placebo","PLACEBO_COMPARATOR","Placebo Injection, SC",[30],"Other: Placebo",{"label":32,"type":33,"description":34,"interventionNames":35},"JKN2401 Injection","EXPERIMENTAL","JKN2401 Injection, SC dose A",[36],"Biological: JKN2401 Injection",[38,42],{"type":39,"name":32,"description":40,"armGroupLabels":41,"otherNames":11},"BIOLOGICAL","JKN2401 subcutaneous injection, Q4W",[32],{"type":43,"name":26,"description":44,"armGroupLabels":45,"otherNames":11},"OTHER","Placebo subcutaneous injection,Q4W",[26],[47],{"name":48,"role":49,"phone":50,"phoneExt":11,"email":51},"Ying Yang","CONTACT","+86-0755-33268688","overseas@joincare.com",{"type":53,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100618337",false,"NCT07330310","A Phase 3 Trial of JKN2401 Injection in COPD","A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous JKN2401 Injection in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)","Inclusion Criteria:\n\n* Written informed consent; able and willing to comply with study procedures.\n* Adults with documented COPD diagnosis and medical history consistent with guideline criteria.\n* Relevant exposure history consistent with COPD (e.g., smoking and\u002For biomass exposure).\n* On stable, guideline-based maintenance COPD therapy prior to randomization, per investigator judgment.\n* Protocol-defined exacerbation history, symptom burden, and lung function at screening.\n\nExclusion Criteria:\n\n* Current or past asthma, or other clinically significant respiratory disease that may confound assessment.\n* Clinically significant uncontrolled comorbidities that increase risk or interfere with participation\u002Foutcomes.\n* Immunodeficiency\u002Fimmune dysregulation, active autoimmune disease requiring systemic immunosuppression, or significant opportunistic infection history.\n* Active clinically significant infection or recent infection requiring systemic therapy; recent protocol-defined COPD exacerbation.\n* Current\u002Frecent malignancy (except low-risk, adequately treated cancers per protocol) or clinically significant abnormal screening labs.\n* Prohibited recent vaccines or therapies, prior relevant biologic\u002Ftargeted therapy exposure, severe hypersensitivity to biologics\u002FIMP, pregnancy\u002Fbreastfeeding, or inability to comply (including substance abuse), per investigator judgment.","ALL","40 Years","80 Years",{"count":64,"type":65},888,"ESTIMATED","INTERVENTIONAL",[68],"PHASE3",[70],"Chronic Obstructive Pulmonary Disease (COPD)",[72],"JKN2401","NOT_YET_RECRUITING","2026-01-12",{"date":76,"type":77},"2026-01-14","ACTUAL",{"date":79,"type":65},"2026-03",{"date":81,"type":65},"2027-11",{"name":5,"class":6}]